These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32328155)

  • 1. Computational Study to Identify the Effects of the KCNJ2 E299V Mutation in Cardiac Pumping Capacity.
    Jeong DU; Lee J; Lim KM
    Comput Math Methods Med; 2020; 2020():7194275. PubMed ID: 32328155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational prediction of the effect of D172N KCNJ2 mutation on ventricular pumping during sinus rhythm and reentry.
    Heikhmakhtiar AK; Lee CH; Song KS; Lim KM
    Med Biol Eng Comput; 2020 May; 58(5):977-990. PubMed ID: 32095980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.
    Whittaker DG; Ni H; El Harchi A; Hancox JC; Zhang H
    PLoS Comput Biol; 2017 Jun; 13(6):e1005593. PubMed ID: 28609477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.
    Deo M; Ruan Y; Pandit SV; Shah K; Berenfeld O; Blaufox A; Cerrone M; Noujaim SF; Denegri M; Jalife J; Priori SG
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4291-6. PubMed ID: 23440193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling.
    Adeniran I; El Harchi A; Hancox JC; Zhang H
    Cardiovasc Res; 2012 Apr; 94(1):66-76. PubMed ID: 22308236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
    Priori SG; Pandit SV; Rivolta I; Berenfeld O; Ronchetti E; Dhamoon A; Napolitano C; Anumonwo J; di Barletta MR; Gudapakkam S; Bosi G; Stramba-Badiale M; Jalife J
    Circ Res; 2005 Apr; 96(7):800-7. PubMed ID: 15761194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
    Luo C; Wang K; Zhang H
    Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
    Luo C; Wang K; Zhang H
    Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the KCNQ1 S140G Mutation on Human Ventricular Arrhythmogenesis and Pumping Performance: Simulation Study.
    Jeong DU; Lim KM
    Front Physiol; 2018; 9():926. PubMed ID: 30108508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
    Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
    Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
    Moreno-Manuel AI; Macías Á; Cruz FM; Gutiérrez LK; Martínez F; González-Guerra A; Martínez Carrascoso I; Bermúdez-Jimenez FJ; Sánchez-Pérez P; Vera-Pedrosa ML; Ruiz-Robles JM; Bernal JA; Jalife J
    Cardiovasc Res; 2024 Apr; 120(5):490-505. PubMed ID: 38261726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.
    Lopez-Izquierdo A; Ponce-Balbuena D; Ferrer T; Sachse FB; Tristani-Firouzi M; Sanchez-Chapula JA
    Cell Physiol Biochem; 2009; 24(3-4):153-60. PubMed ID: 19710529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.
    Kharche S; Garratt CJ; Boyett MR; Inada S; Holden AV; Hancox JC; Zhang H
    Prog Biophys Mol Biol; 2008; 98(2-3):186-97. PubMed ID: 19041665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocinnamic Acid Inhibits the Currents of WT and SQT3 Syndrome-Related Mutants of Kir2.1 Channel.
    Ren S; Pang C; Huang Y; Xing C; Zhan Y; An H
    J Membr Biol; 2017 Oct; 250(5):425-432. PubMed ID: 28660286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).
    Tsuboi M; Antzelevitch C
    Heart Rhythm; 2006 Mar; 3(3):328-35. PubMed ID: 16500306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
    Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
    J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
    Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.
    Eckhardt LL; Farley AL; Rodriguez E; Ruwaldt K; Hammill D; Tester DJ; Ackerman MJ; Makielski JC
    Heart Rhythm; 2007 Mar; 4(3):323-9. PubMed ID: 17341397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Electromechanical Delay during Ventricular Tachycardia and Fibrillation under Different Conductivity Conditions Using Computational Modeling.
    Heikhmakhtiar AK; Lim KM
    Comput Math Methods Med; 2020; 2020():9501985. PubMed ID: 32300375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.
    Du C; Rasmusson RL; Bett GC; Franks B; Zhang H; Hancox JC
    Front Pharmacol; 2021; 12():794620. PubMed ID: 35115940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.